We saw a surge in the InMode Ltd. (INMD stock) shares by a percentage of 8.84% to trade at the price of $104.64 in the current market at the last check. Previously the session was closed by INMD stock at $96.14. The INMD stock volume traded 1.28 million shares, while the average daily volume for the past 50 days has been 0.65 million shares traded. INMD stock had surged in the past year up to date by 260.48%, and in the past week, the shares had jumped up by 1.72%. In the past three and six months, the stock has gained 19.15% and added 93.79% respectively. Furthermore, the company is currently valued in the market at $3.55 billion and has outstanding shares that stand at 39.03 million.
What you need to know about InMode as a company
InMode Ltd. is a medical design company that specifically focuses on the development and manufacturing on of medical instruments and devices with proprietary ownership. These medical products are famous in InMode Ltd. because they are known to be minimally-invasive aesthetic medical products. The procedures that the INMD stock specifically focuses on are the aesthetic ones which include the portfolio of skin tightening, face and body contouring, and treatments for ablative skin rejuvenation for example liposuction. However minimally or non-invasive medical procedures is not the only medical service offering because the company provides an array of procedures that contain invasively aesthetic products. These procedures include permanent hair reduction, reduction of wrinkle, treatment of cellulite, facial skin rejuvenation, skin appearance and texture, pigmented lesions, superficial benign vascular and the products that are hands-free medical aesthetic products include skin tightening, fat reduction and muscle stimulation. The company provides its product offering directly in the United States, UK and Canada, Australia, India, and France along with a distributor network in 47 countries. The company was founded in 2008 and has its headquarter based in Yokneam Israel.
Updated release date for the second quarter 2021 financial result
The company released an announcement to provide the investors and shareholders an update on when INMD stock will release the financial result for the second quarter of 2021 on the date of 28th July 2021. The company reported that it is finalizing and organizing its results for the financial operations of the second quarter 2021.
However, the company has had a set of preliminary results that it is expecting which are based on the results and expectations of previous results. The management is expecting to have the revenue of the second quarter 2021 to be somewhere in the range of $86.6 million to $87.0 million. INMD stock has set up a preliminary expectation for its Non-GAAP earnings per diluted share to be somewhere around the range of $1.00 to $1.01. The projected expectation of full-year revenue is being placed between the range of $305 and $315 million. The non-GAAP gross margin for the full year is expected to be in-between 84% to 86%.
The date set up for the release of the financial result is specifically for 28th July 2021, at 8:30 am Eastern Time that will be delivered through a conference call by the management and executives of the team.
